Management of axial signs (postural instability, freezing) and cognitive decline in Parkinson's disease is unsatisfactory with the current medical treatment. Subthalamic nucleus stimulation is an ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Aug. 19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's ...

Learn more: Parkinson’s medications and Alzheimer’s treatment options ... Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions ...

Sildenafil citrate has been found to be safe and effective in the treatment of erectile dysfunction in PD. Clinical diagnosis of Parkinson's disease (PD) could be performed in the presence of ...

for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

Researchers have reported that early exposure to a few antimicrobials, like penicillins and antifungals, could impact the ...

Parkinson's disease and ADHD are genetically linked, finds a brain study that could provide a roadmap for future treatment.